Robert J. Gould

2022 - Fulcrum Therapeutics

In 2022, Robert J. Gould earned a total compensation of $118.3K as Former Interim President and Chief Executive Officer at Fulcrum Therapeutics.

Compensation breakdown

Option Awards$73,342
Other$45,000
Total$118,342

Gould received $73.3K in option awards, accounting for 62% of the total pay in 2022.

Gould also received $45K in other compensation.

Rankings

In 2022, Robert J. Gould's compensation ranked 5,511th out of 5,683 executives tracked by ExecPay. In other words, Gould earned more than 3.0% of executives.

ClassificationRankingPercentile
All
5,511
out of 5,683
3rd
Division
Manufacturing
3,006
out of 3,091
3rd
Major group
Chemicals And Allied Products
1,374
out of 1,406
2nd
Industry group
Drugs
1,281
out of 1,307
2nd
Industry
Pharmaceutical Preparations
927
out of 949
2nd
Source: SEC filing on April 19, 2024.

Gould's colleagues

We found two more compensation records of executives who worked with Robert J. Gould at Fulcrum Therapeutics in 2022.

2022

Bryan Stuart

Fulcrum Therapeutics

Chief Executive Officer

2022

Curtis Oltmans

Fulcrum Therapeutics

Chief Legal Officer

News

In-depth

You may also like